In 2022, the U.S. Supreme Court issued an unprecedented ruling in Dobbs v. Jackson Women’s Health Organization which eliminated the constitutional right to abortion. This decision has led to widespread repercussions with abortion bans in effect in forty-one states, twelve of which have imposed a ban as early as six weeks from conception when many do not know they are pregnant. Pregnancies may result from sexual assault or pose a severe health risk to the pregnant individual; however, exceptions for such circumstances are inconsistent. For instance, both Louisiana and Arkansas have enacted a complete abortion ban with no exceptions for rape or incest whereas Alabama only provides an exception for rape. Despite the diminishing access to abortions in these states, studies have shown that almost all other states have experienced an increase in the number of abortion procedures sought and provided.
As states continue to implement stringent abortion restrictions, alternative options such as medication abortion have become more commonly pursued by pregnant individuals. Medication abortion, also known as “abortion pills,” is a process of ending a pregnancy through remedial measures. The process entails oral administration of two capsules that stop the pregnancy and induce uterine contractions which expel the pregnancy tissue. Notably, in the six months after Dobbs, the provision of prescriptions for self-managed abortions increased. However, anti-abortion groups have encouraged the criminalization of these alternative methods. Notwithstanding political opposition, the Food and Drug Administration (FDA) has approved the use of the medication to safely and effectively end pregnancies of up to eleven weeks.
Amid state bans and limitations on medication abortion, novel constitutional questions about interstate relationships have surfaced. On January 31, 2025, a grand jury in West Baton Rouge Parish, Louisiana indicted a New York physician for allegedly prescribing and mailing abortion pills to a minor. After the indictment, New York Governor Kathy Hochul denied Louisiana Governor Jeff Landry’s request to extradite the physician under the authority of New York’s shield law. While various states have passed “shield laws” to protect doctors from extradition for mailing abortion pills out of state, this is the first instance in which such laws have been tested. In its aftermath, this case sparked fear among medical professionals that merely providing telehealth abortion care, even if permitted by their state, may ultimately lead to persecution.
In light of escalating constraints placed on access to reproductive health care, studies have further revealed that there are many facing significant consequences. Namely, racial and ethnic minority groups are disproportionately represented in pregnancy-related deaths and individuals face increased barriers barring access to contraceptives. Such restrictions are associated with surging infant and neonatal mortality rates and an 11% increase in foster care entries. Hence, the most recently discussed case on medication abortions and shield laws is crucial to safeguard those providing and receiving essential reproductive health care.